Radiative decay lifetimes of CH^-₂

Recently the presence and radiative decay of vibrationally excited CH - 2, generated in a hot cathode discharge of methane, was established by measuring the time dependent photodetachment from excited states of CH - 2 as it radiatively relaxed in a high vacuum ion trap. The time dependence of the photodetachment was found to be consistent with an electron affinity of 5250 cm^−1 (0.65 eV) for ground state X-tilde 3B1 methylene. The radiative decay lifetimes of the first three excited bending vibrations of CH - 2 were also tentatively assigned. Here, we report a more refined analysis of the experimental data along with theoretical ab initio determinations of the radiative decay lifetimes of the first four excited bending vibrational levels of CH - 2. There is some discrepancy between the ab initio values (431, 207, 118, and 68 ms for the v2=1, 2, 3, and 4 levels respectively) and the experimental values (525, 70, and 14 ms for v2=1, 2, and 3 respectively) for v2=2 and 3. Possible reasons for this discrepancy are discussed but none of the alternatives are entirely satisfactory

Constraints on new interactions from neutron scattering experiments

Constraints for the constants of hypothetical Yukawa-type corrections to the Newtonian gravitational potential are obtained from analysis of neutron scattering experiments. Restrictions are obtained for the interaction range between 10^{-12} and 10^{-7} cm, where Casimir force experiments and atomic force microscopy are not sensitive. Experimental limits are obtained also for non-electromagnetic inverse power law neutron-nucleus potential. Some possibilities are discussed to strengthen these constraints.Comment: 18 pages, 3 figure

Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis

Myxovirus A (MxA), a protein encoded by the MX1 gene with antiviral activity, has proven to be a sensitive measure of IFNβ bioactivity in multiple sclerosis (MS). However, the use of MxA as a biomarker of IFNβ bioactivity has been criticized for the lack of evidence of its role on disease pathogenesis and the clinical response to IFNβ. Here, we aimed to identify specific biomarkers of IFNβ bioactivity in order to compare their gene expression induction by type I IFNs with the MxA, and to investigate their potential role in MS pathogenesis. Gene expression microarrays were performed in PBMC from MS patients who developed neutralizing antibodies (NAB) to IFNβ at 12 and/or 24 months of treatment and patients who remained NAB negative. Nine genes followed patterns in gene expression over time similar to the MX1, which was considered the gold standard gene, and were selected for further experiments: IFI6, IFI27, IFI44L, IFIT1, HERC5, LY6E, RSAD2, SIGLEC1, and USP18. In vitro experiments in PBMC from healthy controls revealed specific induction of selected biomarkers by IFNβ but not IFNγ, and several markers, in particular USP18 and HERC5, were shown to be significantly induced at lower IFNβ concentrations and more selective than the MX1 as biomarkers of IFNβ bioactivity. In addition, USP18 expression was deficient in MS patients compared with healthy controls (p = 0.0004). We propose specific biomarkers that may be considered in addition to the MxA to evaluate IFNβ bioactivity, and to further explore their implication in MS pathogenesis

Hold up of dye in the arm during fluorescein angiography: A quantitative demonstration

PURPOSE: To demonstrate a hold-up of part of the fluorescein bolus in the arm as a result of arm position. METHOD: Case report. We obtained a fluorescein angiogram with a calibrated confocal scanning laser ophthalmoscope in a 20-year-old healthy subject. During and after injection, the upper arm was held in approximately 60 degrees abduction, 65 degrees exorotation, and slight anteflexion. In the late venous phase, the subject moved the upper arm on the injected side to a more neutral, downward position. RESULTS: We measured a distinct rise in fluorescence level about 10 seconds after movement of the arm. The most likely explanation is relief of a partial obstruction of the venous drainage, which had been caused by the position of the upper arm described above. CONCLUSION: Impaired venous drainage of the injected arm caused by exorotation and abduction of the upper arm is a potentially common cause of delayed dye arrival or unexpectedly reduced contrast level during fluorescein angiography. Therefore, arm position needs attention in fluorescein angiography. Copyright (C) 2000 Elsevier Science Inc

Metal-insulator multilayer precursors for enhanced Sm²⁺ absorption and Tm²⁺ luminescence in SiAlO thin films prepared by magnetron sputtering

Silicon-aluminum-oxigen (SiAlO) coatings doped with Sm2+ and prepared by reactive magnetron co-sputtering of Si, Al, and Sm targets, are attractive for luminescence solar concentrator applications but suffer from the low absorption between 300 and 600 nm. This article reports that the main cause of low absorption is a high concentration of undesired Sm3+. This finding is supported by optical transmittance, photoluminescence emission and excitation characterization, and X-ray photoelectron spectroscopy data of the Sm's 3d5/2 edge. We present an alternative deposition process for obtaining Sm doped SiAlO layers with enhanced Sm2+ absorption by incorporating Sm through the use of multilayer thin-film precursors composed of metallic Sm and SiAlO layers. After thermal post-deposition treatments, diffusion and reaction of the metallic Sm layers with the SiAlO host results in coatings showing the characteristic 5d → 4f transitions of Sm2+ in the region between 250 and 600 nm which were not detectable in Sm-doped single layers. This same deposition strategy produces Tm doped SiAlO coatings with Tm2+‘s characteristic luminescence at 1132 nm when the SiAlO host is in the mullite composition region. The photoluminescence excitation spectrum of Tm2+ is compared to phosphor with similar composition and covers the range between 300 and 700 nm.</p

Metal-insulator multilayer precursors for enhanced Sm²⁺ absorption and Tm²⁺ luminescence in SiAlO thin films prepared by magnetron sputtering

Silicon-aluminum-oxigen (SiAlO) coatings doped with Sm2+ and prepared by reactive magnetron co-sputtering of Si, Al, and Sm targets, are attractive for luminescence solar concentrator applications but suffer from the low absorption between 300 and 600 nm. This article reports that the main cause of low absorption is a high concentration of undesired Sm3+. This finding is supported by optical transmittance, photoluminescence emission and excitation characterization, and X-ray photoelectron spectroscopy data of the Sm's 3d5/2 edge. We present an alternative deposition process for obtaining Sm doped SiAlO layers with enhanced Sm2+ absorption by incorporating Sm through the use of multilayer thin-film precursors composed of metallic Sm and SiAlO layers. After thermal post-deposition treatments, diffusion and reaction of the metallic Sm layers with the SiAlO host results in coatings showing the characteristic 5d → 4f transitions of Sm2+ in the region between 250 and 600 nm which were not detectable in Sm-doped single layers. This same deposition strategy produces Tm doped SiAlO coatings with Tm2+‘s characteristic luminescence at 1132 nm when the SiAlO host is in the mullite composition region. The photoluminescence excitation spectrum of Tm2+ is compared to phosphor with similar composition and covers the range between 300 and 700 nm.RST/Luminescence MaterialsQN/AfdelingsbureauChemE/O&O groe

Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults

PURPOSE: To identify and prioritize potential topics to be addressed in the development of European multidisciplinary guidelines on the management of chronic kidney disease stage 3b-5 in older patients. METHODS: We composed a list of 47 potential guideline topics by reviewing the literature, consulting online 461 nephrologists and 107 geriatricians, and obtaining expert input. A multidisciplinary panel of twelve experts then prioritized the topics during a face-to-face consensus meeting, following a nominal group technique structure with two voting rounds. Topics were rated on a 9-point scale ranging from 1 ('not at all important') to 9 ('critically important'). RESULTS: The highest rating (median; range) was assigned to 'Screening and referral' (8.5; 2.0). Eight topics shared the second highest rating with a median priority score of 8.0 (2.0) and included 'Starting dialysis or not' and 'Accurate assessment of renal function.' 'Targets for and treatment of diabetes' received the lowest rating with (3.0; 6.0). CONCLUSIONS: This joint initiative of the European Renal Association-European Dialysis Transplant Association (ERA-EDTA) and the European Union Geriatric Medicine Society (EUGMS) prioritized the development of guidance on interdisciplinary referral of older patients with chronic kidney disease stage 3b-5. Future guidance will therefore focus on identifying prognostic scores to predict death and progression to end-stage renal disease, as well as accurate tests for assessment of renal function in older kidney patients. This will contribute to more informed treatment decision making in this growing patient population